Skip to main content
. 2023 Dec 22;15(3):e00669. doi: 10.14309/ctg.0000000000000669

Table 4.

Reason for discontinuation of therapy during maintenance therapy with tofacitinib between weeks 8 and 52

Study withdrawal reason n %
Discontinuation of tofacitinib due to lack of efficacy 31 77.5%
Surgery (colectomy) 5 12.5%
Lack of patient's cooperation with survey completion 2 5.0%
Discontinuation of tofacitinib due to intolerance or adverse event 1 2.5%
Othera 1 2.5%
a

Patient became pregnant and stopped the medication.